GB1456513A - Derivatives of cyclopentaneacetic acid - Google Patents
Derivatives of cyclopentaneacetic acidInfo
- Publication number
- GB1456513A GB1456513A GB2395076A GB2395076A GB1456513A GB 1456513 A GB1456513 A GB 1456513A GB 2395076 A GB2395076 A GB 2395076A GB 2395076 A GB2395076 A GB 2395076A GB 1456513 A GB1456513 A GB 1456513A
- Authority
- GB
- United Kingdom
- Prior art keywords
- proviso
- double bond
- compounds
- trans
- trimethoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30481372A | 1972-11-08 | 1972-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1456513A true GB1456513A (en) | 1976-11-24 |
Family
ID=23178133
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2395076A Expired GB1456513A (en) | 1972-11-08 | 1973-11-07 | Derivatives of cyclopentaneacetic acid |
| GB5175873A Expired GB1456512A (en) | 1972-11-08 | 1973-11-07 | Substituted 16,17,18,19,20-pentanorprostaglandins |
| GB2285876A Expired GB1456514A (en) | 1972-11-08 | 1973-11-07 | Substituted dialkyl 2-oxopropylphosphonates |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5175873A Expired GB1456512A (en) | 1972-11-08 | 1973-11-07 | Substituted 16,17,18,19,20-pentanorprostaglandins |
| GB2285876A Expired GB1456514A (en) | 1972-11-08 | 1973-11-07 | Substituted dialkyl 2-oxopropylphosphonates |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5416491B2 (enExample) |
| AR (3) | AR200585A1 (enExample) |
| AT (3) | AT367034B (enExample) |
| AU (1) | AU470375B2 (enExample) |
| BE (1) | BE806995A (enExample) |
| CA (3) | CA1085831A (enExample) |
| CH (1) | CH597176A5 (enExample) |
| CS (3) | CS182793B2 (enExample) |
| DD (4) | DD118856A5 (enExample) |
| DE (1) | DE2355540C2 (enExample) |
| DK (1) | DK144247C (enExample) |
| ES (3) | ES420325A1 (enExample) |
| FI (1) | FI60389C (enExample) |
| FR (3) | FR2205335B1 (enExample) |
| GB (3) | GB1456513A (enExample) |
| HK (3) | HK27979A (enExample) |
| HU (3) | HU172703B (enExample) |
| IE (1) | IE39537B1 (enExample) |
| IL (1) | IL43589A (enExample) |
| IN (1) | IN139384B (enExample) |
| KE (3) | KE2930A (enExample) |
| MY (3) | MY7900246A (enExample) |
| NL (1) | NL164273C (enExample) |
| NO (3) | NO147836C (enExample) |
| PH (3) | PH13272A (enExample) |
| SE (4) | SE448992B (enExample) |
| SU (4) | SU584766A3 (enExample) |
| YU (3) | YU39715B (enExample) |
| ZA (1) | ZA738554B (enExample) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US7388029B2 (en) | 2000-03-31 | 2008-06-17 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
| US8618086B2 (en) | 2000-03-31 | 2013-12-31 | Duke University | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| US3986764A (en) * | 1975-03-31 | 1976-10-19 | Gte Automatic Electric Laboratories Incorporated | Panel for supporting a pair of elongated mating connectors and selectively locking them together |
| GB1506817A (en) * | 1975-03-31 | 1978-04-12 | Upjohn Co | Prostaglandins |
| ES449162A1 (es) * | 1975-06-23 | 1977-12-16 | Syntex Inc | Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico. |
| GB1516414A (en) * | 1975-08-22 | 1978-07-05 | Ici Ltd | Prostane derivatives |
| SE7809008L (sv) * | 1977-12-12 | 1979-06-13 | Upjohn Co | Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter |
| DK523378A (da) * | 1978-01-16 | 1979-07-17 | Pfizer | Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf |
| ID24845A (id) * | 1997-09-09 | 2000-08-24 | Procter & Gamble | Prostaglandin tetrahidro tersubstitusi c16-c20 aromatik yang berguna sebagai agonis fp |
| JP2002329615A (ja) * | 2001-05-02 | 2002-11-15 | Ohira Denshi Kk | トロイダルコイル |
| US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| WO2006047466A2 (en) | 2004-10-21 | 2006-05-04 | Duke University | Ophthamological drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
-
1972
- 1972-11-07 DD DD182498*A patent/DD118856A5/xx unknown
-
1973
- 1973-10-29 SE SE7314686A patent/SE448992B/xx unknown
- 1973-11-07 AR AR250885A patent/AR200585A1/es active
- 1973-11-07 DD DD182499*A patent/DD119411A5/xx unknown
- 1973-11-07 IL IL43589A patent/IL43589A/en unknown
- 1973-11-07 CA CA185,274A patent/CA1085831A/en not_active Expired
- 1973-11-07 FI FI3443/73A patent/FI60389C/fi active
- 1973-11-07 AU AU62247/73A patent/AU470375B2/en not_active Expired
- 1973-11-07 DE DE2355540A patent/DE2355540C2/de not_active Expired
- 1973-11-07 BE BE1005485A patent/BE806995A/xx not_active IP Right Cessation
- 1973-11-07 PH PH15191A patent/PH13272A/en unknown
- 1973-11-07 YU YU2880/73A patent/YU39715B/xx unknown
- 1973-11-07 GB GB2395076A patent/GB1456513A/en not_active Expired
- 1973-11-07 AT AT0936973A patent/AT367034B/de not_active IP Right Cessation
- 1973-11-07 JP JP12527273A patent/JPS5416491B2/ja not_active Expired
- 1973-11-07 DD DD174504A patent/DD109212A5/xx unknown
- 1973-11-07 GB GB5175873A patent/GB1456512A/en not_active Expired
- 1973-11-07 FR FR7339544A patent/FR2205335B1/fr not_active Expired
- 1973-11-07 GB GB2285876A patent/GB1456514A/en not_active Expired
- 1973-11-07 ZA ZA738554A patent/ZA738554B/xx unknown
- 1973-11-07 NO NO4288/73A patent/NO147836C/no unknown
- 1973-11-07 DD DD182497*A patent/DD117233A5/xx unknown
- 1973-11-07 ES ES420325A patent/ES420325A1/es not_active Expired
- 1973-11-07 DK DK601073A patent/DK144247C/da not_active IP Right Cessation
- 1973-11-07 CH CH1563973A patent/CH597176A5/xx not_active IP Right Cessation
- 1973-11-07 NL NL7315263.A patent/NL164273C/xx not_active IP Right Cessation
- 1973-11-07 IE IE2002/73A patent/IE39537B1/xx unknown
- 1973-11-07 IN IN2448/CAL/73A patent/IN139384B/en unknown
- 1973-11-08 HU HU72PI00000399A patent/HU172703B/hu unknown
- 1973-11-08 CS CS7500006065A patent/CS182793B2/cs unknown
- 1973-11-08 HU HU73PI00000452A patent/HU171819B/hu unknown
- 1973-11-08 CS CS7500006066A patent/CS182794B2/cs unknown
- 1973-11-08 HU HU73PI451A patent/HU173507B/hu unknown
- 1973-11-08 CS CS7300007669A patent/CS182791B2/cs unknown
- 1973-11-11 SU SU7301971722A patent/SU584766A3/ru active
-
1974
- 1974-06-06 AR AR254091A patent/AR199966A1/es active
- 1974-06-06 AR AR254090A patent/AR202931A1/es active
- 1974-09-26 NO NO743493A patent/NO148998C/no unknown
- 1974-12-18 ES ES433047A patent/ES433047A1/es not_active Expired
- 1974-12-18 ES ES433046A patent/ES433046A1/es not_active Expired
-
1975
- 1975-02-18 NO NO750535A patent/NO149139C/no unknown
- 1975-02-18 SU SU752106791A patent/SU667141A3/ru active
- 1975-02-19 SU SU752106125A patent/SU893130A3/ru active
- 1975-07-24 PH PH17409A patent/PH13325A/en unknown
- 1975-07-24 PH PH17410A patent/PH13110A/en unknown
- 1975-08-22 FR FR7526060A patent/FR2283146A1/fr active Granted
- 1975-08-22 FR FR7526059A patent/FR2279729A1/fr active Granted
-
1976
- 1976-07-23 AT AT544676A patent/AT353285B/de active
- 1976-07-23 AT AT544576A patent/AT360672B/de not_active IP Right Cessation
- 1976-10-15 JP JP51123737A patent/JPS5253841A/ja active Pending
- 1976-10-15 JP JP51123738A patent/JPS5257147A/ja active Pending
-
1977
- 1977-01-24 SE SE7700718A patent/SE431756B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700716A patent/SE445111B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700717A patent/SE436278B/xx not_active IP Right Cessation
- 1977-07-11 CA CA341,897A patent/CA1088930A/en not_active Expired
- 1977-07-11 CA CA341,898A patent/CA1088931A/en not_active Expired
-
1978
- 1978-07-27 SU SU782629453A patent/SU745362A3/ru active
-
1979
- 1979-03-15 KE KE2930A patent/KE2930A/xx unknown
- 1979-03-15 KE KE2931A patent/KE2931A/xx unknown
- 1979-03-15 KE KE2932A patent/KE2932A/xx unknown
- 1979-05-03 HK HK279/79A patent/HK27979A/xx unknown
- 1979-05-03 HK HK281/79A patent/HK28179A/xx unknown
- 1979-05-03 HK HK280/79A patent/HK28079A/xx unknown
- 1979-12-30 MY MY246/79A patent/MY7900246A/xx unknown
- 1979-12-30 MY MY243/79A patent/MY7900243A/xx unknown
- 1979-12-30 MY MY245/79A patent/MY7900245A/xx unknown
-
1980
- 1980-10-23 YU YU2707/80A patent/YU36975B/xx unknown
- 1980-10-23 YU YU2706/80A patent/YU37316B/xx unknown
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
| US7074942B2 (en) | 1999-08-04 | 2006-07-11 | The Procter & Gamble Company | 2-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US7115659B2 (en) | 1999-08-04 | 2006-10-03 | The Procter & Gamble Company | Method of treating a condition by administering a prostaglandin derivative |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US8618086B2 (en) | 2000-03-31 | 2013-12-31 | Duke University | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US8541466B2 (en) | 2000-03-31 | 2013-09-24 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US7388029B2 (en) | 2000-03-31 | 2008-06-17 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US8906962B2 (en) | 2000-03-31 | 2014-12-09 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US9579270B2 (en) | 2000-03-31 | 2017-02-28 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US9675539B2 (en) | 2000-03-31 | 2017-06-13 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7614201L (sv) | Sett att framstella ftalaner | |
| GB1494191A (en) | Preparation of alpha-acyloxy aldehydes and ketones | |
| GB1505305A (en) | Benzcycloamide derivatives | |
| SE7700716L (sv) | Prostaglandiner | |
| GB1394542A (en) | Optically active isomers of hydroxyamines | |
| GB1451999A (en) | Quinone derivatives | |
| GB1424211A (en) | Substituted ehters and their use as insecitides | |
| GB1216945A (en) | Novel imidazoline derivatives, the preparation thereof and compositions containing the same | |
| GB1439724A (en) | Berbine derivatives and pharmaceutical compositions containing them | |
| GB1274744A (en) | Novel naphthyl acetaldehydes and derivatives thereof | |
| GB1360279A (en) | Styryl compounds processes for theirmanufacture and their use | |
| GB1398191A (en) | Pyrido-pyrimidones and their use as herbicidal agents | |
| GB1375901A (en) | Oxygenated cycloaliphatic compounds | |
| GB1388180A (en) | Acetals | |
| GB1424341A (en) | Diketoesters | |
| GB1497161A (en) | Naphthyl derivatives | |
| GB1363658A (en) | Benzobicycloalkane compounds | |
| GB1354431A (en) | Thiophene and furan derivatives | |
| GB1456511A (en) | P-biphenylyl esters of 15-substituted-16,17,18,19,20-pentanor prostaglandins | |
| GB1361863A (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
| GB1412932A (en) | Pharmaceutically active leurosine derivatives and preparation thereof | |
| GB1344839A (en) | Sulphoniobutadiene salts and their production | |
| GB1378964A (en) | Pyridine derivatives | |
| GB1440601A (en) | Oxaprostaglandins | |
| GB1336547A (en) | Omega-4-phenyl-piperazinyl-alkane-1,2-diols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19921107 |